Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
Clinical trial NCT05411198 · COMPLETED
Trial details
- NCT number
- NCT05411198
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2026-02-04
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.